Bozic Carmen
- SEC CIK
- 0001790029
在各公司的最新職務
- VRTX VERTEX PHARMACEUTICALS INC / MAEVP and CMO2026/6/30 申報
交易紀錄
所有把 Bozic Carmen 列為申報人的 Form 4，包括與他人共同申報的。每一列是一份申報裡同一種交易的合計；預設只顯示公開市場買進（P）與賣出（S）。
| 公司 | 申報時間（美東） | 交易日 | 內部人 | 交易 | 股數 | 均價 | 金額 | 交易後持股 | 持股變化 | 申報 |
|---|---|---|---|---|---|---|---|---|---|---|
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2026/6/30 | 2026/6/26 | Bozic CarmenEVP and CMO | S賣出Common Stock | −596 | $482.50 | −$28.76 萬 | 1.53 萬 | −3.7% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2026/6/23 | 2026/6/18 | Bozic CarmenEVP and CMO | S賣出Common Stock | −1,020 | $462.17 | −$47.14 萬 | 1.59 萬 | −6.0% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2026/6/17 | 2026/6/15 | Bozic CarmenEVP and CMO | S賣出Common Stock | −4,062 | $450.00 | −$182.79 萬 | 1.7 萬 | −19.3% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2026/6/9 | 2026/6/5 | Bozic CarmenEVP and CMO | S賣出Common Stock | −1,745 | $450.00 | −$78.53 萬 | 2.1 萬 | −7.7% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2026/6/2 | 2026/5/29 | Bozic CarmenEVP and CMO | S賣出Common Stock | −1,974 | $450.00 | −$88.83 萬 | 2.28 萬 | −8.0% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2026/5/19 | 2026/5/15 | Bozic CarmenEVP and CMO | S賣出Common Stock | −1,354 | $453.45 | −$61.4 萬 | 2.47 萬 | −5.2% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2026/5/14 | 2026/5/12 | Bozic CarmenEVP and CMO | S賣出Common Stock | −6,988 | $450.00 | −$314.46 萬 | 2.61 萬 | −21.1% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2026/3/31 | 2026/3/27 | Bozic CarmenEVP and CMO | S賣出Common Stock | −2,329 | $450.95 | −$105.03 萬 | 3.31 萬 | −6.6% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2026/3/17 | 2026/3/13 | Bozic CarmenEVP and CMO | S賣出Common Stock | −2,329 | $481.79 | −$112.21 萬 | 3.54 萬 | −6.2% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2026/3/3 | 2026/2/27 | Bozic CarmenEVP and CMO | S賣出Common Stock | −2,329 | $480.31 | −$111.86 萬 | 3.77 萬 | −5.8% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2024/8/8 | 2024/8/7 | Bozic CarmenEVP and CMO | S賣出Common Stock | −2,280 | $476.75 | −$108.7 萬 | 2.33 萬 | −8.9% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2024/7/25 | 2024/7/24 | Bozic CarmenEVP and CMO | S賣出Common Stock | −2,280 | $488.46 | −$111.37 萬 | 2.55 萬 | −8.2% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2024/7/12 | 2024/7/10 | Bozic CarmenEVP and CMO | S賣出Common Stock | −2,280 | $487.34 | −$111.11 萬 | 2.78 萬 | −7.6% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2024/6/28 | 2024/6/26 | Bozic CarmenEVP and CMO | S賣出Common Stock | −2,280 | $471.72 | −$107.55 萬 | 3.01 萬 | −7.0% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2024/6/13 | 2024/6/12 | Bozic CarmenEVP and CMO | S賣出Common Stock | −2,280 | $478.00 | −$108.98 萬 | 3.24 萬 | −6.6% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2024/5/31 | 2024/5/29 | Bozic CarmenEVP and CMO | S賣出Common Stock | −2,280 | $445.56 | −$101.59 萬 | 3.47 萬 | −6.2% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2023/11/16 | 2023/11/14 | Bozic CarmenEVP and CMO | S賣出Common Stock | −5,650 | $380.82 | −$215.16 萬 | 2.93 萬 | −16.2% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2023/11/2 | 2023/10/31 | Bozic CarmenEVP and CMO | S賣出Common Stock | −5,651 | $355.92 | −$201.13 萬 | 3.5 萬 | −13.9% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2023/10/19 | 2023/10/17 | Bozic CarmenEVP and CMO | S賣出Common Stock | −5,651 | $373.25 | −$210.92 萬 | 4.06 萬 | −12.2% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2023/10/5 | 2023/10/3 | Bozic CarmenEVP and CMO | S賣出Common Stock | −5,651 | $345.28 | −$195.12 萬 | 4.63 萬 | −10.9% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2023/9/21 | 2023/9/19 | Bozic CarmenEVP and CMO | S賣出Common Stock | −5,651 | $351.00 | −$198.35 萬 | 5.19 萬 | −9.8% | SEC10b5-1 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2023/9/7 | 2023/9/5 | Bozic CarmenEVP and CMO | S賣出Common Stock | −5,651 | $352.66 | −$199.29 萬 | 5.76 萬 | −8.9% | SEC10b5-1 |